NYSE:EL

Estee Lauder (EL)

83.49
+0.59 (0.71%)
as of Jun 5, 2026, 8:00:00 pm Market Open.
24 watching
0
Investor Insights
star iconJun 5, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

Estee Lauder (EL-N) has garnered mixed reviews from experts, with one highlighting a significant return of 68% in a short time frame, indicating successful technical and fundamental alignment at the time of investment. However, there is a cautious outlook suggesting that the stock may have peaked in its potential gains. On the other hand, another expert points to a decline in the stock's price, framing it as an opportunity for investors. They believe that with the beauty industry's growth driven by influencers, Estee Lauder, despite experiencing some setbacks, is positioned for a potential turnaround. Analysts also provide a price target of $66.95, signaling expectations of future growth. This juxtaposition of opinions indicates a mix of optimism and caution surrounding the company's performance moving forward.

consensus icon
Consensus
Positive
valuation icon
Valuation
Undervalued
review icon
Similar
L'Oréal, LRLCY
DON'T BUY

A disaster. Used to be great. The CEO is not doing a good job.

HOLD
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

EL’s share price is under tremendous pressure recently due to the weak guidance. Still, at 52X earnings the stock is still on the expensive side, even with a 28% YTD decline.  Based on consensus estimates, sales are expected to decline by around -10% this year and start to recover back to 2022’s level in 2024. We think EL still possesses a strong portfolio of worldwide recognized brands for skincare, makeup, fragrance, etc. and these brands have been around for decades and demonstrated consumer loyalty and significant pricing power over the years. Most consumer discretionary names experienced a short-term headwind due to the concern of economic recession. In the last quarter EPS missed estimates. For 2023, EPS is expected to decline by close to 50%. But, nearly 50% growth is expected in a 2024 recovery. Thus, this is a tough call. Momentum is negative, and there are still risks. Valuation is high, but we think that is because investors believe in the rebound possibility. We have recession risk, but the balance sheet is OK (some debt but not an onerous amount). Sentinment is very negative, so any positive news at all should be good for the stock. We would thus be willing to hold to see how the next two quarters fare. 
Unlock Premium - Try 5i Free

HOLD

Upgraded today, but down 25% YTD. It has missed the last three quarters and most recently guided down due to supply chain issues and China reopening slowly and travel retail (mostly from Asia) being down 43%. But ex-travel retail rose 10% last quarter, so eventually these will work. Eventually, China will right itself and sentiment has fallen enough.

DON'T BUY

Is linked to China whose reopening has been much slower than expected, so EL isn't doing well lately. 

BUY ON WEAKNESS
Allan Tong’s Discover Picks

It’s a safe bet to assume that the return of the Chinese traveller will boost EL’s bottom line. Rather, it’s a question of how much and how fast? The company itself has beaten its last four quarters. The market is giving shares the benefit of the doubt as EL trades just under 58x PE, above its five-year average of 55.31x and higher than in 2022, but a third during the December 2020 peak. Read China reopens for our full analysis.

BUY

Expects a good quarter next week.

BUY

Will benefit from China's reopening and has long performed well there. 

BUY
SBUX and Estee Lauder

Today marks the first day that American business executives can fly to China after three years. Those American companies which already have a strong presence in China can get a major boost from this reopening. The company was thriving before the reopening, so imagine what happens now.

BUY
Down 33% so far this year, due China's lockdowns (a major market). Covid could explode there, then subside, because that's what Covid does. Has rebounded 37% from last month's lows. This looks great for 2023.
COMMENT
It reports next week. Eager to hear results. She doesn't own a lot of consumer discretionary. It's a prestige brand and could grow its market share and margins over time, but even though the PE is pricey. Problem is they rely on China where Covid restrictions are an overhang.
PARTIAL SELL
She trimmed this due to issues in China. Trades at an expensive 36x PE. She just sold some shares.
BUY
The return of travel and possible loosening of restrictions in China are tailwinds.
WAIT
It reports Thursday. They drop that ball in their last report because of China. This week, see if they will buy Tom Ford, the highest-end fashion company. This would mark a big change of direction.
WATCH
A predictable, quality company though the PE is too high (though not bad); he prefers 20x PE. Is watching it. There is 80% insider ownership, which can be positive, though not always. In other words, he's neutral about this issue of ownership. Can they compete in China? It's a massive market, but very difficult to survive here. Too risky for him. EL has tremendous brands and nicely grow, overall, though.
BUY ON WEAKNESS
Use of free cashflow, family ownership? Prestige cosmetics negatively affected by Covid. Owns a number of brands. Global. Great business economics, strong balance sheet, management looks good. Valuation is high at 30x earnings, with free cashflow 2%. Consistent free cashflow generator for a decade, reasonable capital allocation. If you have your heart set on buying, wait for weakness.
Showing 16 to 30 of 60 entries